Abstract

.Vietnam is endemic for dengue. We conducted a series of retrospective and prospective studies to characterize the epidemiology of dengue and population mobility patterns in Nha Trang city, Vietnam, with a view to rational design of trials of community-level interventions. A 10-year time series of dengue case notifications showed pronounced interannual variability, as well as spatial heterogeneity in ward-level dengue incidence (median annual coefficient of variation k = 0.47). Of 451 children aged 1–10 years enrolled in a cross-sectional serosurvey, almost one-third had evidence of a past dengue virus (DENV) infection, with older children more likely to have a multitypic response indicative of past exposure to ≥ 1 serotype. All four DENV serotypes were detected in hospitalized patients during 8 months of sampling in 2015. Mobility data collected from 1,000 children and young adults via prospective travel diaries showed that, although all ages spent approximately half of their daytime hours (5:00 am–9:00 pm) at home, younger age groups (≤ 14 years) spent a significantly greater proportion of their time within 500 m of home than older respondents. Together these findings inform the rational design of future trials of dengue preventive interventions in this setting by identifying 1) children < 7 years as an optimal target group for a flavivirus-naive serological cohort, 2) children and young adults as the predominant patient population for a study with a clinical end point of symptomatic dengue, and 3) substantial spatial and temporal variations in DENV transmission, with a consequent requirement for a trial to be large enough and of long enough duration to overcome this heterogeneity.

Highlights

  • Dengue is a vector-borne tropical infectious disease that poses a public health challenge in over 100 countries.[1]

  • The disease is caused by dengue viruses (DENVs), of which there are four serotypes: DENV1–4.2,3 Dengue is an acute systemic febrile illness in which a small proportion of cases develop lifethreatening complications.[2,3,4,5]

  • From 2006 to 2016, a total of 12,655 dengue cases were notified in Nha Trang city, ranging from 285 to 2,335 cases per year

Read more

Summary

Introduction

Dengue is a vector-borne tropical infectious disease that poses a public health challenge in over 100 countries.[1] The disease is caused by dengue viruses (DENVs), of which there are four serotypes: DENV1–4.2,3 Dengue is an acute systemic febrile illness in which a small proportion of cases develop lifethreatening complications.[2,3,4,5] An estimated 50–100 million people worldwide suffer from a clinically apparent DENV infection each year,[1,6] of an estimated 390 million (95% credible interval [CI]: 284–528 million) total annual DENV infections.[1] DENVs are transmitted between humans by Aedes mosquitoes, with Aedes aegypti the primary vector and Aedes albopictus a secondary vector. A vaccine for dengue, Dengvaxia®, developed by Sanofi Pasteur, was trialled in Vietnam but is yet to be licensed locally and has a challenging use profile.[12,13,14,15]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call